<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413942"><TermName>Angiozyme</TermName><TermPronunciation>(AN-jee-oh-zime)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. Angiozyme is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor  receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called RPI.4610.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713325" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Angiozyme&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713324" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Angiozyme&quot;" language="es" id="_4"/><SpanishTermName>Angiozyme</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Angiozyme es un tipo especial de ARN producido en el laboratorio. Impide que se elabore una proteína que se llama receptor del factor de crecimiento endotelial vascular (RFCEV). Esto puede prevenir la formación de  nuevos vasos sanguíneos que los tumores necesitan para crecer.   Es un tipo de inhibidor de la angiogénesis y un tipo de ribozima.   También se llama RPI.4610.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished><DateLastModified>2010-08-27</DateLastModified></GlossaryTerm>
